0001415889-23-005819.txt : 20230403 0001415889-23-005819.hdr.sgml : 20230403 20230403174626 ACCESSION NUMBER: 0001415889-23-005819 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230330 FILED AS OF DATE: 20230403 DATE AS OF CHANGE: 20230403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Bobae CENTRAL INDEX KEY: 0001959158 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 23794127 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 3 1 form3-04032023_090415.xml X0206 3 2023-03-30 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001959158 Kim Bobae 44 PROSPECT ST. APT. 536 MORRISTOWN NJ 07960 false true false false VP Reg. Affairs & Quality Common Stock 9890 D Restricted Stock Units 0 Common Stock 11000 D Stock Options (right to buy) 21 2026-09-30 Common Stock 133 D Stock Options (right to buy) 7.35 2026-12-07 Common Stock 266 D Stock Options (right to buy) 33 2028-03-22 Common Stock 1200 D Stock Options (right to buy) 13.20 2029-01-02 Common Stock 1000 D Stock Options (right to buy) 7.50 2029-09-26 Common Stock 1166 D Stock Options (right to buy) 1.52 2033-02-10 Common Stock 50000 D Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. The restricted stock units are scheduled to vest on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date. Not Applicable. Fully vested and exercisable. This option was granted on September 26, 2019. This option vests in quarterly installments over a four-years period from the date of grant. This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter. /s/ Bobae Kim 2023-04-03